Targeting Myeloid-Derived Suppressor Cells with Ibrutinib Enhances Therapeutic Response to Anti-PD-L1 Immune Checkpoint Blockade S. H. Sun,D. Sundi, D. Abood,B. Benner, M. DiVincenzo,M. Duggan, F. Chouiery,T. A. Mace,P. Trikha,W. E. CarsonANNALS OF SURGICAL ONCOLOGY（2020）引用 0|浏览17暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
